Jamieson Wellness (TSE:JWEL) Given New C$38.00 Price Target at Royal Bank of Canada

Jamieson Wellness (TSE:JWELFree Report) had its price objective lifted by Royal Bank of Canada from C$37.00 to C$38.00 in a research note released on Friday,BayStreet.CA reports.

A number of other analysts have also recently commented on JWEL. Canaccord Genuity Group upped their price target on Jamieson Wellness from C$32.50 to C$36.25 in a research note on Friday, August 9th. TD Securities raised their price target on shares of Jamieson Wellness from C$40.00 to C$42.00 and gave the stock a “buy” rating in a research note on Friday. Finally, BMO Capital Markets increased their price objective on Jamieson Wellness from C$35.00 to C$42.00 in a report on Friday, August 9th.

Check Out Our Latest Report on JWEL

Jamieson Wellness Price Performance

TSE JWEL traded up C$1.94 on Friday, hitting C$35.62. 125,093 shares of the company were exchanged, compared to its average volume of 61,116. The company has a current ratio of 3.21, a quick ratio of 1.08 and a debt-to-equity ratio of 92.76. Jamieson Wellness has a 1-year low of C$23.98 and a 1-year high of C$35.90. The company has a market cap of C$1.48 billion, a P/E ratio of 41.42 and a beta of 0.63. The firm has a 50 day moving average of C$33.95 and a two-hundred day moving average of C$30.60.

Insider Buying and Selling at Jamieson Wellness

In related news, Senior Officer Regan Stewart sold 8,732 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of C$31.65, for a total value of C$276,373.04. In related news, Senior Officer Regan Stewart sold 8,732 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of C$31.65, for a total value of C$276,373.04. Also, Senior Officer Donald Bird sold 38,861 shares of the company’s stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of C$31.23, for a total transaction of C$1,213,562.97. Insiders have sold a total of 72,058 shares of company stock worth $2,307,317 over the last ninety days. Insiders own 0.26% of the company’s stock.

About Jamieson Wellness

(Get Free Report)

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.

Recommended Stories

Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.